English | Español

Regulatory
+ Regulatory
John Breslin | May 26, 2017

Physicians accuse Blue Cross Blue Shield of breaking the law by denying emergency care coverage
+ Regulatory
Tabitha Fleming | May 26, 2017

National Institute on Alcohol Abuse and Alcoholism releases 5-year action plan

+ Regulatory
Erianne Leatherman | May 24, 2017

Proposed changes in Medicare Advantage, Part D plans for 2018 could bring slight increase
+ Regulatory
Erianne Leatherman | May 23, 2017

Apricus begins erectile dysfunction drug-applicator study
+ Regulatory
Robert Hadley | May 16, 2017

Immunosuppressive drug cladribine may slow progression of MS
+ Regulatory
Robert Hadley | May 14, 2017

Bristol-Myers Squibb dual-drug treatment for hepatitis C gains China approval
+ Regulatory
Cheyenne Dickerson | May 11, 2017

European Commission approves Tagrisso for treating non-small cell lung cancer
+ Regulatory
Robert Hadley | May 11, 2017

NanoViricides says it's close to trials for topical shingles treatment

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes